Durvalumab in Frail and Elderly Patients With Stage Four Non-Small Cell Lung Cancer: Study Protocol of the Randomized Phase II DURATION Trial
Trials - United Kingdom
doi 10.1186/s13063-020-04280-8
Full Text
Open PDFAbstract
Available in full text
Date
April 22, 2020
Authors
Publisher
Springer Science and Business Media LLC